<DOC>
	<DOCNO>NCT00448786</DOCNO>
	<brief_summary>The study involve use three different dose regimen AMG 706 patient advance solid tumor see drug affect gallbladder size function . The study conduct 11 site US Australia . A total 48 patient enrol study possibility enrol 8 treatment arm .</brief_summary>
	<brief_title>Effect Different Doses AMG 706 Gallbladder Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Histologically confirm advanced metastatic solid tumor Ineligible receive progress standard care therapy Measurable nonmeasurable disease per modify RECIST Gallbladder must situ screen ultrasound ECOG Performance Status 0 2 Life expectancy 6 month determine investigator Adequate organ hematologic function evidence laboratory study prior randomization Men woman 18 year old Uncontrolled CNS metastasis Known history prior cholecystitis , prior biliary procedure prior ongoing biliary disease Radiation therapy within 14 day prior randomization Peripheral neuropathy &gt; Grade 1 per CTC AE v.3 Currently previously treat AMG 706 VEGF inhibitor SU11248 ( sunitinib ) , PTK787 ( vatalanib ) , AZD2171 , BAY 439006 ( sorafenib ) , ZD6474 ( vandetanib ) Previous treatment bevacizumab allow least 6 week elapse last dose bevacizumab date randomization Any anticoagulant therapy within 7 day prior randomization ; low dose heparin warfarin prophylaxis central venous catheter thrombosis allow Less 30 day elapse since participation investigational drug/device study currently receive investigational treatment History arterial venous thrombosis within 1 year prior randomization History bleed diathesis bleeding within 14 day randomization MI , CVA , TIA , PTCA/stent , CHF , Grade 2 great PVD , uncontrolled arrhythmias unstable angina within one year prior randomization Uncontrolled HTN define rest BP &gt; 150/90 mmHg Surgery : major surgical procedure within 4 week 28 day prior randomization ; minor surgical procedure , placement access device fine needle aspiration within 7 day randomization ; plan elective surgery study Nonhealing open wound , ulcer fracture Known ongoing active infection Known ( + ) HIV , Hep C Hep B surface antigen Known chronic hepatitis Known history allergy hypersensitivity AMG 706 component Pregnant , ie , ( + ) bHCG ; breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>gallbladder</keyword>
	<keyword>AMG 706</keyword>
	<keyword>solid tumor</keyword>
	<keyword>Phase 1b</keyword>
	<keyword>Amgen</keyword>
</DOC>